University at Buffalo neuroscientists have identified the binding site of low-dose ketamine, providing critical insight into how the medication, often described as a wonder drug, alleviates symptoms of major depression in as little as a few hours with effects lasting for several days.

ADA Forsyth scientists have developed a new imaging approach that makes it possible to analyze the spatial connections between bacteria, including the strength of adhesive forces that binds different microbes together, to determine the strength of their interactions.

Researchers at Monroe Carell Jr. Children’s Hospital at Vanderbilt are seeking to determine the age when infants are most susceptible to the risk of developing childhood asthma once exposed to antibiotics and the pathways through which infant antibiotic use can increase the risk childhood asthma onset.

Ohio University College of Arts and Sciences Professor Dr. Mitchell Day has been awarded a significant grant of $453,000 from the National Institutes of Health (NIH) to explore the neurobiological mechanisms behind hearing loss and its impact on sound localization. This innovative research aims to shed light on how hearing impairment affects auditory perception, particularly in complex environments.

Researchers at Washington University School of Medicine in St. Louis have used AI tools to describe three sub-types of Chiari type-1, which will help guide clinicians to make the most effective treatment decisions for their patients. Chiari type-1 malformation is a condition in which the cerebellum extends beyond the gap in the skull where it connects to the spinal cord.